Ex Parte Johansson et al - Page 9

                   Appeal 2007- 2552                                                                                                
                   Application 10/276,428                                                                                           
                           While Amalric does not disclose the use of the formulation of claim                                      
                   20 as a hard surface cleaner, there is no structural difference in the                                           
                   formulation as claimed which would patentability differentiate the claimed                                       
                   composition from that of Amalric.  Claim recitations that merely set forth                                       
                   the intended use for an otherwise old composition do not differentiate the                                       
                   claimed composition from those known in the prior art.  In re Pearson, 494                                       
                   F.2d 1399, 1302, 181 USPQ 641, 644 (CCPA 1974).                                                                  
                           Appellants contend that they have illustrated the “surprising effect of                                  
                   branched alkyl glycosides” in Table 1 on page 9 of the Specification.  They                                      
                   state that “[i]n order to form a microemulsion with the linear C10/C12 alkyl                                     
                   glucoside [sic], 1 dodecanol must be present in an amount of at least 5.5%.”                                     
                   (Br. 9).  Appellants do not address any particular claim, therefore, we select                                   
                   claim 1 and decide the issue based on that claim.                                                                
                           As a first matter, Appellants have not sufficiently proven that their                                    
                   compositions are indeed different than those claimed.  If the composition is                                     
                   in fact the same, there can be no unexpected result; the result will inherently                                  
                   occur when one follows the teachings of the reference.                                                           
                           Secondly, the fact that a cosurfactant such as 1-dodecanol must be                                       
                   present to form the microemulsion when linear C10/C12 alkyl glycosides are                                       
                   present tends to support the Examiner’s determination that Amalric forms a                                       
                   microemulsion.  This is because Amalric uses fatty alcohols such as                                              
                   dodecanol to formulate an emulsion (FF 6).  The presence of the fatty                                            
                   alcohols in the composition of Amalric indicates that these alcohols serve as                                    
                   cosurfactants such that a microemulsion is formed.                                                               
                           Third, claim 1 does not exclude the presence of fatty alcohol                                            
                   cosurfactants such as 1-dodecanol.  "[O]bjective evidence of                                                     

                                                                 9                                                                  

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next

Last modified: September 9, 2013